EHDS-ART53-PROHIB | Prohibited Secondary Use Purposes | 0 |
EHDS-ART8A | Telemedicine in the context of cross-border care | 0 |
EHDS-HOLD-1 | Obligation to Make Data Available | 0 |
EHDS-HOLD-2 | Secure Processing Environment | 0 |
EHDS-HOLD-3 | Dataset Descriptions and Catalogues | 54 |
EHDSREG-1 | Mandatory Requirements for EHR Systems (Articles 14-29) | 132 |
EHDSREG-2 | Primary Use - Right to Restrict Access and Rectification | 0 |
EHDSREG-3 | Secondary Use - Health Data for Research and Innovation | 13 |
EHDSREG-4 | Digital Health Authorities, Governance, MyHealth@EU | 41 |
EHDSREG-5 | Cross-Border Health Data Flows | 69 |
EHDSREG-6 | Phased Application and Enforcement | 58 |
104 | Use the EHDS conformity route to show Cyber Resilience Act conformity for EHR systems | 0 |
11 | Give health professionals access to the relevant priority data of their patients, including across borders | 0 |
13 | Register priority-category data electronically, keep it updated and record who changed it | 0 |
15(4) | Issue priority data in the European exchange format and accept it when received | 0 |
16 | Identify patients and professionals electronically for cross-border exchange under the 2026 identification act | 0 |
18 | Never charge patients or receiving providers for making or sharing health data | 0 |
19 | Designate resourced, independent digital health authorities by 26 March 2027 | 0 |
20 | Publish a biennial activity report of the digital health authority | 0 |
21 | Receive and route complaints, and let data protection authorities enforce patient rights with GDPR-level fines | 0 |
23 | Run a national contact point for digital health, connect every provider and dispense foreign e-prescriptions | 0 |
26 | Place or put into service only EHR systems whose harmonised components comply with Chapter III | 0 |
27 | Medical devices and high-risk AI claiming EHR interoperability must meet the Annex II component requirements | 0 |
28 | Make no misleading claims about an EHR system's purpose, interoperability or security | 0 |
3 | Give patients immediate, free, readable access to and a download of their priority health data | 0 |
30 | Meet the manufacturer duties: conformity, documentation, declaration, CE marking, contact details and registration | 0 |
30(1)(i) | Correct, withdraw or recall non-conforming systems and keep complaint and non-conformity registers | 0 |
31 | Non-EU manufacturers: appoint an EU authorised representative with a sufficient written mandate | 0 |
32 | Importers: verify conformity before supply, keep records and act on non-conformity | 0 |
33 | Distributors: check marking and documents before supply and report non-conformity | 0 |
35 | Identify suppliers and customers of EHR systems to authorities for 10 years | 0 |
37 | Draw up Annex III technical documentation and produce it within 30 days of a request | 0 |
38 | Supply an information sheet stating identity, version, purpose, data categories and standards supported | 0 |
39 | Issue an Annex IV EU declaration of conformity and affix the CE marking before placing on the market | 0 |
4 | Operate free patient access services with proxy and legal-representative functions | 0 |
40 | Test the harmonised components in the digital testing environment before placing on the market | 0 |
43 | Designate market surveillance authorities and act on risk and non-compliance | 0 |
44(7) | Report serious incidents involving an EHR system within three days | 0 |
47 | Label wellness apps that claim EHR interoperability and never share data automatically | 0 |
49 | Register EHR systems and labelled wellness apps in the EU database before placing on the market | 0 |
5 | Let patients add information to their record and request rectification online | 0 |
51 | Make the minimum data categories available for secondary use unless exempt | 0 |
52 | Flag data protected by IP, trade secrets or regulatory data protection and justify the protection | 0 |
55 | Designate health data access bodies by 26 March 2027 with resources and segregated functions | 0 |
57 | Run the access body tasks: decide, prepare data, supervise, and publish permits and refusals | 0 |
59 | Publish a biennial access body activity report with the required statistics | 0 |
60 | Deliver requested data within three months and keep dataset descriptions accurate | 0 |
61 | Health data users: process only under the permit, never re-identify, publish results within 18 months | 0 |
62 | Charge only transparent, cost-based fees and disclose estimates before issuing a permit | 0 |
63 | Enforce against users and holders, with fines of up to 20 million euro or 4 percent of turnover | 0 |
66 | Give only necessary data, anonymised where possible and pseudonymised only with justification | 0 |
67 | Submit complete access applications with purpose, data, safeguards and pseudonymisation justification | 0 |
68 | Decide on permits within three months against the Article 68 criteria and set permit conditions | 0 |
69 | Answer health data requests only in anonymised statistical form within the set periods | 0 |
7 | Transmit patient data to another provider or reimbursement body immediately, free and without hindrance | 0 |
71 | Provide an easy, reversible opt-out from secondary use and apply it to later permits | 0 |
72 | Trusted health data holders: assess requests within two months and provide the secure environment | 0 |
73 | Provide permitted data only in a secure processing environment with the Article 73 controls and audits | 0 |
74 | Document the controller and processor roles along the secondary-use chain | 0 |
75 | Designate a national contact point for secondary use and connect it to HealthData@EU | 0 |
77 | Describe datasets with the HealthDCAT-AP minimum metadata in the national catalogue | 0 |
78 | Label publicly funded datasets with a data quality and utility label | 0 |
8 | Honour patient restrictions and any national primary-use opt-out, with a vital-interest override that is logged | 0 |
81 | Provide complaint tools on secondary use and route opt-out complaints to data protection authorities | 0 |
83 | Train health professionals and promote patients' digital health literacy | 0 |
85 | Reference the EHDS specifications in public procurement and funding conditions | 0 |
87 | Store and process personal data for secondary use inside the EU or an adequacy country | 0 |
89 | Resist unlawful third-country access to non-personal health data and transfer personal data only under GDPR Chapter V | 0 |
9 | Show patients who accessed their data, when and what, for at least three years | 0 |
91 | Accept third-country applications only from authorised or reciprocal countries | 0 |
99 | Lay down and notify penalties by 26 March 2027 and allow compensation claims | 0 |
Annex II-2 | Build the interoperability component to export, receive and not obstruct data in the exchange format | 0 |
Annex II-3 | Authenticate professionals reliably and log every access event with the required fields | 0 |
IR2083 | Pass MyHealth@EU compliance checks, fix findings within set deadlines and report significant incidents within 24 hours | 0 |
MACHINERY | Commission, EHDS Board, stakeholder forum and steering groups | 0 |
REGULATION | Regulation (EU) 2025/327: scope and definitions | 0 |
STATUS | Status: in force since 26 March 2025, nothing applies before 26 March 2027, staged to 2035 | 0 |